{
  "primary": "G3BP1",
  "interaction_type": "indirect",
  "upstream_interactor": null,
  "mediator_chain": [],
  "depth": 1,
  "support_summary": "ATXN3 interacts with the stress granule nucleator G3BP1, and G3BP1 overexpression has been shown to reduce the aggregation of mutant ATXN3.",
  "functions": [
    {
      "function": "Mutant ATXN3 Levels and Aggregation",
      "arrow": "activates",
      "cellular_process": "G3BP1, a key nucleator of stress granules, plays a protective role in the context of spinocerebellar ataxia type 3 (SCA3). Instead of a direct enzymatic regulation, G3BP1 influences the cellular environment to reduce the burden of the mutant ATXN3 protein.",
      "effect_description": "Overexpression of G3BP1 leads to a significant reduction in the total protein levels of polyglutamine-expanded (mutant) ATXN3. This decrease in the soluble protein pool consequently leads to a marked reduction in the formation of mutant ATXN3 aggregates, thereby alleviating cellular toxicity and neuropathology in SCA3 models.",
      "biological_consequence": [
        "G3BP1 levels are increased (e.g., via overexpression) → Cellular protein homeostasis is altered → Mutant ATXN3 protein levels are reduced → Formation of toxic mutant ATXN3 aggregates is decreased → Neuronal protection and amelioration of motor deficits in SCA3 models."
      ],
      "specific_effects": [
        "Reduces total protein levels of mutant ATXN3.",
        "Decreases the number of cells with mutant ATXN3 aggregates.",
        "Silencing of G3BP1 increases mutant ATXN3 aggregation."
      ],
      "evidence": [
        {
          "paper_title": "The stress granule protein G3BP1 alleviates spinocerebellar ataxia-associated deficits",
          "journal": "Brain",
          "year": 2023,
          "relevant_quote": "Our results indicate that G3BP1 overexpression in cell models leads to a reduction of ATXN2 and ATXN3 aggregation, associated with a decrease in protein expression. This protective effect of G3BP1 against polyglutamine protein aggregation was reinforced by the fact that silencing G3bp1 in the mouse brain increases human expanded ATXN2 and ATXN3 aggregation.",
          "pmid": "36511898"
        }
      ],
      "pathway": {
        "name": "Protein Aggregation",
        "canonical_name": "Protein Aggregation",
        "ontology_id": null,
        "ontology_source": null,
        "confidence": 0.8
      },
      "pmids": [
        "36511898"
      ],
      "interaction_effect": "activates",
      "interaction_direction": "primary_to_main",
      "function_effect": "activation",
      "arrow_context": {
        "direct_from": null,
        "direct_arrow": "activates",
        "net_from": "ATXN3",
        "net_arrow": "activates",
        "mediator_chain": [],
        "is_indirect": true
      },
      "net_arrow": "activates",
      "direct_arrow": "activates",
      "net_effect": "activation",
      "direct_effect": "activation"
    }
  ],
  "arrow": "regulates",
  "direction": "primary_to_main",
  "intent": "regulation",
  "arrows": {
    "main_to_primary": [
      "activates"
    ]
  },
  "is_valid": true,
  "mechanism_correction": "The input correctly identifies an interaction but mischaracterizes the effect as 'activates'. The primary literature demonstrates an inhibitory relationship: G3BP1 overexpression reduces the protein levels and aggregation of mutant ATXN3. This is a protective, inhibitory effect on the pathogenic protein, not an activation.",
  "mechanism": "G3BP1, a key nucleator of stress granules, plays a protective role in the context of spinocerebellar ataxia type 3 (SCA3). Instead of a direct enzymatic regulation, G3BP1 influences the cellular environment to reduce the burden of the mutant ATXN3 protein.",
  "effect": "Overexpression of G3BP1 leads to a significant reduction in the total protein levels of polyglutamine-expanded (mutant) ATXN3. This decrease in the soluble protein pool consequently leads to a marked reduction in the formation of mutant ATXN3 aggregates, thereby alleviating cellular toxicity and neuropathology in SCA3 models.",
  "summary": "ATXN3 inhibits G3BP1 to modulate regulation of mutant atxn3 levels and aggregation, ultimately affecting neuronal protection and amelioration of motor deficits in sca3 models.",
  "evidence": [
    {
      "paper_title": "The stress granule protein G3BP1 alleviates spinocerebellar ataxia-associated deficits",
      "journal": "Brain",
      "year": 2023,
      "relevant_quote": "Our results indicate that G3BP1 overexpression in cell models leads to a reduction of ATXN2 and ATXN3 aggregation, associated with a decrease in protein expression. This protective effect of G3BP1 against polyglutamine protein aggregation was reinforced by the fact that silencing G3bp1 in the mouse brain increases human expanded ATXN2 and ATXN3 aggregation."
    }
  ],
  "pathways": [
    {
      "name": "Protein Aggregation",
      "canonical_name": "Protein Aggregation",
      "ontology_id": null,
      "ontology_source": null,
      "confidence": 0.8
    }
  ],
  "interaction_effect": "regulation",
  "_validation_metadata": {
    "validated": true,
    "validator": "arrow_effect_validator",
    "corrections_applied": 4
  },
  "_arrow_validated": true,
  "arrow_notation": "ATXN3 <--regulates-- G3BP1:",
  "protein_a": "ATXN3",
  "protein_b": "G3BP1",
  "discovered_in_query": "ATXN3",
  "first_discovered": "2025-11-30T15:37:50.133461Z",
  "last_updated": "2025-11-30T15:37:50.133461Z"
}